Toulouse, February 12th 2015 – VEXIM (FR0011072602 – ALVXM), a medical device company specializing in the minimally-invasive treatment of vertebral fractures, today announces extensive IP protection of its new high performance cement delivery system MASTERFLOW®.
Thanks to unique and innovative technologies, the MASTERFLOW® allows for optimal precision, control and safety during injection of intra-vertebral cement. The cleverly designed hydraulic pump enables smooth displacement of high viscosity cement through a small diameter needle. Another essential feature of the device is the use of a zero-inertia membrane and quick-stop button arrangement, allowing the operator to instantly stop cement delivery and prevent excessive cement leakages.
As many as 18 patent applications were filed across the world to protect these innovative features. A number of those are now being granted in key European countries, the United States and China, as well as in Japan, Canada, Australia, Korea and Russia.
Vincent Gardès, CEO of VEXIM, concludes: “Our IP strategy is a cornerstone of our innovation management process. Granted patents in that many key countries are a strong demonstration of the value of the technology behind the MASTERFLOW® system. It really boosts our confidence in the future success of this new device.”
